Andrea Carenzo
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
CINSARC and Sarculator in Patients with Primary Retroperitoneal Sarcoma: A Combined Analysis of Single-Institution Data and the EORTC-STBSG-62092 Trial (STRASS).
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 09, 2025
An Inflammatory Signature to Predict the Clinical Benefit of First-Line Cetuximab Plus Platinum-Based Chemotherapy in Recurrent/Metastatic Head and Neck Cancer.
Journal: Cells
Published: September 03, 2022
hacksig: a unified and tidy R framework to easily compute gene expression signature scores.
Journal: Bioinformatics (Oxford, England)
Published: December 30, 2021
Biological properties of hypoxia-related gene expression models/signatures on clinical benefit of anti-EGFR treatment in two head and neck cancer window-of-opportunity trials.
Journal: Oral oncology
Published: December 23, 2021
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report.
Journal: Frontiers in oncology
Published: November 03, 2021
Clinical Validity of a Prognostic Gene Expression Cluster-Based Model in Human Papillomavirus-Positive Oropharyngeal Carcinoma.
Journal: JCO precision oncology
Published: March 01, 2021
Complexity index in sarcoma and genomic grade index gene signatures in rhabdomyosarcoma of pediatric and adult ages.
Journal: Pediatric blood & cancer
Published: November 06, 2020
AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: October 21, 2020
Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions.
Journal: Cells
Published: June 30, 2020
Last Updated: 09/26/2026